Immunotherapy Stocks List

Symbol Grade Name
CLDX Celldex Therapeutics, Inc.
FBIO Fortress Biotech, Inc.
NLNK NewLink Genetics Corporation
CDMO Avid Bioservices, Inc.
CVM Cel-Sci Corporation
IMUX Immunic, Inc.
GNCA Genocea Biosciences, Inc.
ENLV Enlivex Therapeutics Ltd.
DBVT DBV Technologies S.A.
APTO Aptose Biosciences, Inc.
BLCM Bellicum Pharmaceuticals, Inc.
IOVA Iovance Biotherapeutics, Inc.
CDTX Cidara Therapeutics, Inc.
ADAP Adaptimmune Therapeutics plc
ONCS OncoSec Medical Incorporated
CLBS Caladrius Biosciences, Inc.
ALPN Alpine Immune Sciences, Inc.
AIMT Aimmune Therapeutics, Inc.
PDSB PDS Biotechnology Corporation
SELB Selecta Biosciences, Inc.
MRKR Marker Therapeutics, Inc.
JNCE Jounce Therapeutics, Inc.
ARGX argenx SE
IMRN Immuron Limited
MBIO Mustang Bio, Inc.
FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
CDMOP Avid Bioservices, Inc. - 10.50% Series E Convertible Preferred Stock
RCUS Arcus Biosciences, Inc.
UMRX Unum Therapeutics Inc.
SURF Surface Oncology, Inc.
IMV IMV Inc.
REPL Replimune Group, Inc.
ARDS Aridis Pharmaceuticals Inc.
GRTS Gritstone Oncology, Inc.
AVCO Avalon GloboCare Corp.
INMB INmune Bio Inc.
HARP Harpoon Therapeutics, Inc.
TCRR TCR2 Therapeutics Inc.
DTIL Precision BioSciences, Inc.
NXTC NextCure, Inc.

Recent Signals

Date Stock Signal Type
2019-06-21 ADAP Crossed Above 20 DMA Bullish
2019-06-21 ADAP Bollinger Band Squeeze Range Contraction
2019-06-21 AIMT Fell Below 20 DMA Bearish
2019-06-21 AIMT Bollinger Band Squeeze Range Contraction
2019-06-21 ALPN Narrow Range Bar Range Contraction
2019-06-21 APTO Shooting Star Candlestick Bearish
2019-06-21 APTO Fell Below 200 DMA Bearish
2019-06-21 APTO Lizard Bearish Bearish Day Trade Setup
2019-06-21 ARDS 50 DMA Support Bullish
2019-06-21 ARDS Pocket Pivot Bullish Swing Setup
2019-06-21 ARDS Wide Range Bar Range Expansion
2019-06-21 ARDS Volume Surge Other
2019-06-21 ARDS 200 DMA Support Bullish
2019-06-21 ARGX Slingshot Bullish Bullish Swing Setup
2019-06-21 ARGX New 52 Week High Strength
2019-06-21 ARGX New 52 Week Closing High Bullish
2019-06-21 AVCO 20 DMA Resistance Bearish
2019-06-21 BLCM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-06-21 BLCM Stochastic Reached Overbought Strength
2019-06-21 BLCM New Uptrend Bullish
2019-06-21 BLCM 20 DMA Support Bullish
2019-06-21 CDMO 20 DMA Resistance Bearish
2019-06-21 CDMO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-06-21 CDMO Spinning Top Other
2019-06-21 CDMOP Volume Surge Other
2019-06-21 CDMOP Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-06-21 CDMOP Fell Below 20 DMA Bearish
2019-06-21 CDTX 20 DMA Support Bullish
2019-06-21 CLBS New 52 Week Closing Low Bearish
2019-06-21 CVM Upper Bollinger Band Walk Strength
2019-06-21 CVM Pocket Pivot Bullish Swing Setup
2019-06-21 DBVT Spinning Top Other
2019-06-21 DBVT NR7 Range Contraction
2019-06-21 DBVT Narrow Range Bar Range Contraction
2019-06-21 DTIL Upper Bollinger Band Walk Strength
2019-06-21 ENLV Upper Bollinger Band Walk Strength
2019-06-21 ENLV Narrow Range Bar Range Contraction
2019-06-21 ENLV NR7 Range Contraction
2019-06-21 ENLV Calm After Storm Range Contraction
2019-06-21 FBIO 50 DMA Resistance Bearish
2019-06-21 FBIO 20 DMA Resistance Bearish
2019-06-21 FBIO Bollinger Band Squeeze Range Contraction
2019-06-21 FBIO Narrow Range Bar Range Contraction
2019-06-21 FBIO NR7 Range Contraction
2019-06-21 GNCA 1,2,3 Pullback Bullish Bullish Swing Setup
2019-06-21 GNCA Narrow Range Bar Range Contraction
2019-06-21 GNCA NR7-2 Range Contraction
2019-06-21 GNCA NR7 Range Contraction
2019-06-21 GRTS Stochastic Sell Signal Bearish
2019-06-21 GRTS Pocket Pivot Bullish Swing Setup
2019-06-21 GRTS Upper Bollinger Band Walk Strength
2019-06-21 HARP Upper Bollinger Band Walk Strength
2019-06-21 HARP Stochastic Reached Overbought Strength
2019-06-21 HARP Volume Surge Other
2019-06-21 IMRN NR7 Range Contraction
2019-06-21 IMRN NR7-2 Range Contraction
2019-06-21 IMRN Narrow Range Bar Range Contraction
2019-06-21 IMUX Fell Below 20 DMA Bearish
2019-06-21 IMV Bullish Engulfing Bullish
2019-06-21 IMV Doji - Bullish? Reversal
2019-06-21 IMV Lower Bollinger Band Walk Weakness
2019-06-21 INMB Stochastic Reached Oversold Weakness
2019-06-21 IOVA Slingshot Bullish Bullish Swing Setup
2019-06-21 IOVA Upper Bollinger Band Walk Strength
2019-06-21 JNCE NR7 Range Contraction
2019-06-21 JNCE 20 DMA Support Bullish
2019-06-21 MBIO Crossed Above 50 DMA Bullish
2019-06-21 MBIO Crossed Above 20 DMA Bullish
2019-06-21 MBIO Wide Range Bar Range Expansion
2019-06-21 MBIO Bollinger Band Squeeze Range Contraction
2019-06-21 MBIO 180 Bullish Setup Bullish Swing Setup
2019-06-21 MBIO Expansion Pivot Buy Setup Bullish Swing Setup
2019-06-21 MBIO Pocket Pivot Bullish Swing Setup
2019-06-21 MRKR Volume Surge Other
2019-06-21 MRKR Pocket Pivot Bullish Swing Setup
2019-06-21 MRKR Expansion Breakout Bullish Swing Setup
2019-06-21 MRKR Upper Bollinger Band Walk Strength
2019-06-21 MRKR Wide Range Bar Range Expansion
2019-06-21 NXTC New 52 Week Closing Low Bearish
2019-06-21 ONCS 20 DMA Support Bullish
2019-06-21 PDSB Lower Bollinger Band Walk Weakness
2019-06-21 PDSB Stochastic Reached Oversold Weakness
2019-06-21 PDSB Bollinger Band Squeeze Range Contraction
2019-06-21 RCUS 50 DMA Resistance Bearish
2019-06-21 REPL Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-06-21 REPL Crossed Above 20 DMA Bullish
2019-06-21 SELB MACD Bearish Signal Line Cross Bearish
2019-06-21 SELB Bollinger Band Squeeze Range Contraction
2019-06-21 SELB Narrow Range Bar Range Contraction
2019-06-21 SELB NR7-2 Range Contraction
2019-06-21 SELB NR7 Range Contraction
2019-06-21 SURF Narrow Range Bar Range Contraction
2019-06-21 TCRR 50 DMA Resistance Bearish
2019-06-21 TCRR Volume Surge Other
2019-06-21 TCRR 20 DMA Support Bullish
2019-06-21 UMRX New Downtrend Bearish
2019-06-21 UMRX New 52 Week Low Weakness
2019-06-21 UMRX NR7 Range Contraction
2019-06-21 UMRX New 52 Week Closing Low Bearish

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapy